BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Earlier This Year

This week, brand name drug giants AbbVie, AstraZeneca and Amgen all announced earnings and profits for the second quarter of 2022 that topped Wall Street analysts’ expectations. The Big Pharma giants reported blockbuster earnings and revenue estimates after hiking drug prices on American patients over the summer – on top of additional price hikes at the beginning of the year.

AbbVie

AstraZeneca

Amgen

The blockbuster earnings and profits come as Big Pharma companies have continued to hike prices on their prescription drugs, despite a growing crisis of affordability.

AbbVie

AstraZeneca

AstraZeneca has a long history of hiking prices on Americans struggling to afford their medications:

Amgen

Read more on second-quarter earnings from Big Pharma giants Johnson & Johnson, Roche and Novartis HERE.

Read more on Q2 earnings from Pfizer, Merck, Bristol Myers Squibb, GlaxoSmithKline and Sanofi HERE.

Stay tuned as we continue to monitor earnings calls from Big Pharma for the second quarter of the year.

Learn more about bipartisan, market-based solutions to lower prescription drug prices and hold Big Pharma accountable HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.